The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...
Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
Fact checked by Nick Blackmer The Food and Drug Administration (FDA) on Thursday approved Journavx (suzetrigine), a new non-opioid painkiller that promises to be nonaddictive. Journavx is approved to ...